BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BioStar Pharmaceuticals Inc. Announces Appointment of New Chief Financial Officer; Appoints Audit Committee Chairman and Independent Director to the Board of Directors XIANYANG, China, April 12, 2011 – Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) (“Biostar” or “the Company”), Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules (“Xin Aoxing Capsules”), in addition to a portfolio]

By | 2016-03-03T13:01:31+00:00 April 12th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BioStar Pharmaceuticals Announces Appointment of New Chief Financial Officer; Appoints Auditmmittee Chairman and Independent Director to the Board of Directors Finally, thempanyso announced that the Board has appointed Mr. King-fai (Patrick) Leung an independent director to the Board and Chairman of theAuditmmittee to fill vacancies resulting from Mr. Pans departures, discussedove.]

By | 2016-02-07T16:19:12+00:00 April 12th, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

LEDS [SemiLEDs] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended February 28, 2011 or o For the transition period from to SemiLEDs Corporation Delaware 20-2735523 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number)] [Loan Agreement (Used for Short-term, Medium-term, and Long-term Loan) Agreement Borrower Guarantor Obligors Bank This Loan Agreement (the “ 1. Term The Borrower may apply loan to the Bank in accordance with the Agreement during the term from October 28, 2010 to October 28, 2011 (the “ 2. The take-down and the lending period should be made in accordance with] [E xhibit 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Trung Tri Doan, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, David Young, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: April 12, 2011 1 EX-32.1 5 a11-9940_1ex32d1.htm EX-32.1] [CERTIFICATION SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: April 12, 2011 1 EX-32.2 6 a11-9940_1ex32d2.htm EX-32.2]

By | 2016-04-03T06:36:45+00:00 April 12th, 2011|Categories: Chinese Stocks, LEDS, SEC Original|Tags: , , , , , |0 Comments

CHOP [China Gerui Advanced Materials] 6-K: (Original Filing)

[Company Contact: investors@geruigroup.com Email: Website: www.geruigroup.com Investor Relations Contact: CCG Investor Relations Mr. Athan Dounis Phone: 1-646-213-1916 athan.dounis@ccgir.com Email: China Gerui Advanced Materials Group Limited Announces Fourth Quarter and Full Year 2010 Results ZHENGZHOU, China Full Year 2010 Highlights l Revenue increased 16.0% to $253.9 million l Gross profit increased 15.5% to $76.0 million l Gross margin was 29.9% l] [Company Contact: investors@geruigroup.com Email: Website: www.geruigroup.com Investor Relations Contact: CCG Investor Relations Mr. Athan Dounis Phone: 1-646-213-1916 athan.dounis@ccgir.com Email: China Gerui Advanced Materials Group Announces $10 Million Share Repurchase Program ZHENGZHOU, China "Based on current market prices, we believe that the repurchase program is in the best interests of our shareholders," said Mr. Mingwang Lu, Chairman and Chief Executive Officer.] [1 Shuanghu Development Zone Xinzheng City Zhengzhou, Henan Province China, 451191 x o o x On April 7, 2011, China Gerui Advanced Materials Group Limited (the “Company”) issued a press release announcing its financial results for the fiscal quarter and fiscal year ended December 31, 2010. Description 99.1 Press release regarding financial results, dated April 7, 2011 99.2 Press release]

MY [CHINA MING YANG WIND POWER] 20-F: (Original Filing)

[INTRODUCTION 1 PART I 1 Item 1. Identity of Directors, Senior Management and Advisors 1 Item 2. Offer Statistics And Expected Timetable 1 Item 3. Key Information 1 Item 4 Information of the Company 34 Item 4A. Unresolved Staff Comments 67 Item 5. Operating and Financial Review and Prospects 67 Item 6. Directors, Senior Management and Employees 94 Item 7.] [THE COMPANIES LAW (2010 REVISION) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF CHINA MING YANG WIND POWER GROUP LIMITED (ADOPTED BY A SPECIAL RESOLUTION PASSED ON AUGUST 31, 2010 AND EFFECTIVE CONDITIONAL AND IMMEDIATELY UPON THE COMMENCEMENT OF THE TRADING OF THE COMPANY’S AMERICAN DEPOSITARY SHARES REPRESENTING ITS ORDINARY SHARES] [• First Base Investment Limited (incorporated in Hong Kong) • KeyCorp Limited (incorporated in Hong Kong) • Sky Trillion Limited (incorporated in the British Virgin Islands) • King Venture Limited (incorporated in Hong Kong) • Tech Sino Limited (incorporated in Hong Kong) • Asiatech Holdings Limited (incorporated in Hong Kong) • Rich Wind Energy Two Corp. (incorporated in the British] [Certification by the Chief Executive Officer I, Chuanwei Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of China Ming Yang Wind Power Group Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [Certification by the Chief Financial Officer I, Manfred Loong, certify that: 1. I have reviewed this annual report on Form 20-F of China Ming Yang Wind Power Group Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [Certification by the Chief Executive Officer (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Chuanwei Zhang Chief Executive Officer] [Certification by the Chief Financial Officer (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Manfred Loong Chief Financial Officer]

By | 2016-03-01T02:26:26+00:00 April 11th, 2011|Categories: Chinese Stocks, MY, SEC Original|Tags: , , , , , |0 Comments

OIIM [O2MICRO INTERNATIONAL] SC 13G/A: (Original Filing)

[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-K: (Original Filing)

[TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED DECEMBER 31, 2010 Page 3] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer April 11, 2011 EX-32.1 6 v218099_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Michael H. Lan Chief Financial Officer April 11, 2011 EX-32.2 7 v218099_ex32-2.htm]

By | 2016-03-01T05:25:01+00:00 April 11th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Skip to toolbar